baber/WOPTO huggingface dataset:
Patent NZ-331665-A (NZ)
Title: Monitoring a synchronous digital hierarchy transmission path
Inventor: HERSHEY PAUL CHRISTIAN
IPC: H04J3/16
Filed: 1997-03-18
Abstract: here is described a system for monitoring utilisation of a tributary (17) to a main SDH transmission path (15).  The main SDH transmission path is arranged to transport a series of data frames, each of which contains virtual containers. A data signal from tributary (17) is loaded into virtual containers reserved to carry the data signal. The monitoring system (20) comprises an optical service unit (21) and a computer (22).  The optical service unit (21) monitors the bytes of the virtual containers reserved to carry the tributary for the presence of a predetermined bit pattern and transmits a report containing the results of the monitoring to the computer (22).  In the computer (22), the data contained in the report is used to evaluate utilisation of the tributary. One example of the bit pattern which is monitored is the presence of all binary "1"s in each byte of the payload of a virtual container.
Patent NZ-335382-A (NZ)
Title: Multi-functional chimeric hematopoietic polypeptides of IL-3, GCSF, Flt3L, EPO, stem cell factor, cmpl link with or without linker group consisting of Alanine, Glycine and/or Serine for treating autoimmune and tumour related diseases
Inventor: MCWHERTER CHARLES A
IPC: C07K14/54
Filed: 1997-10-23
Abstract: A multi-functional chimeric hematopoietic protein comprising an amino acid sequence of the formula: R1-L1-R2,   R2-L1-R1,   R1-R2   or R2-R1 Wherein R1 and R2 are independently selected from the group consisting of; (I) A human EPO receptor agonist polypeptide, comprising a modified EPO as shown in Sequence ID 464, wherein 1-6 amino acids from the N-terminus and/or 1-5 from the C-terminus are optionally deleted. The N-terminus is joined to the C-terminus directly or through a linker (L2). (II) A human stem cell factor receptor agonist polypeptide comprising a modified stem cell factor as shown in Sequence ID 465, wherein 1-23 amino acids are optionally deleted from the C-terminus. The N-terminus is joined to the C-terminus directly or through a linker (L2). (III) A human flt-3 receptor agonist polypeptide comprising a modified flt-3 ligand as shown in Sequence ID 466, wherein 1-7 amino acids are optionally deleted from the C-terminus. The N-terminus is joined to the C-terminus directly or through a linker (L2). (IV) A human G-CSF polypeptide comprising a modified human G-CSF as shown in Sequence ID 858, wherein Xaa may be replaced with any of the disclosed amino acids and 1-11 amino acids and/or 1-5 amino acids are optionally deleted from the C-terminus. The N-terminus is joined to the C-terminus directly or through a linker (L2). (V) A human IL-3 polypeptide comprising a modified human IL-3 as shown in Sequence ID 859 whereupon the modified IL-3 is circularly permuted, wherein Xaa may be replaced with any of the disclosed amino acids and 1-14 amino acids and/or 1-15 amino acids are optionally deleted from the C-terminus and amino acids 0-44 designated Xaa are different to the corresponding native human IL-3 (1-133). The N-terminus is joined to the C-terminus directly or through a linker (L2). (VI) A human c-mpl ligand polypeptide comprising a modified human c-mpl ligand as shown in Sequence ID 860, wherein Xaa may be replaced with any of the disclosed amino acids. The N-terminus is joined to the C-terminus directly or through a linker (L2). (VII) A human IL-3 polypeptide comprising a modified human IL-3 as shown in Sequence ID 859, wherein Xaa may be replaced with any of the disclosed amino acids and 1-14 amino acids and/or 1-15 amino acids are optionally deleted from the C-terminus and amino acids 0-44 designated Xaa are different to the corresponding native human IL-3 (1-133). The N-terminus is joined to the C-terminus directly or through a linker (L2). (VIII) A factor selected from the group consisting of a colony stimulating factor, a cytokine, a lymphokine, an interleukin and a hematopoietic growth factor; and L1 is a linker capable of linking R1 to R2, with the proviso that R1 and R2 is selected from the polypeptide of the Formula (I), (II) or (III).
Patent NZ-336793-A (NZ)
Title: Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
Inventor: FURUYA HIDEYUKI
IPC: A61K47/12
Filed: 1998-01-19
Abstract: The method of stabilizing a peptide containing the sequence -Asp-Gly or -Asn-Gly which sequence may be susceptible to conversion into a succinimide moiety of formula 1 or a b-rearranged moiety of formula 2 comprises: a) providing a solution of a peptide, b) adding an organic acid and adjusting the pH of the solution to 5 to 6.5 and c) lyophilizing the resulting mixture.. The organic acid can be tartaric acid, citric acid or acetic acid and the peptide can be a hirudin variant or desulphatohirudin. Saccharose and mannitol can also be added to the solution.
Patent NZ-337580-A (NZ)
Title: Allergen formulation comprising tyrosine, allergen and MPL, preparation and use to treat allergies
Inventor: ULRICH JORJ TERRY
IPC: A61P37/08
Filed: 1998-04-03
Abstract: A pharmaceutical composition comprising tyrosine, an optionally modified allergen, and 3-DMPL useful in the prevention and treatment of allergy.
Patent NZ-500368-A (NZ)
Title: Synergistic fungicidal combinations comprising a halogeno-benzimidazole and a triazole
Inventor: STENZEL KLAUS
IPC: A01N43/828
Filed: 1998-04-06
Abstract: The specification describes synergistic fungicidal compositions comprising a halageno-benzimidazole depicted by formula (I) above and described in WO97/06171a triazole of above formula (II). Suitable triazoles are disclosed in patents NZ 169506,  NZ 174 233,  the Pesticide Manual 9th Edition (1991) pp 249 & 827 and EP 0 382 375 and EP 0 515 901.
Patent NZ-505566-A (NZ)
Title: A non-ionic polymer (polyalkene oxide) and a non-ionic or anionic material (phenolic material) used to separate water from sludge
Inventor: TREMONT STEPHEN ROBERT
IPC: C02F11/147
Filed: 1999-01-07
Abstract: A sludge, preferably derived at least in part from a paper mill, pulp mill or deinking plant, and which contains at least secondary sludge or primary sludge comprising deinking waste, recycled paper waste or mechanical pulping waste, is flocculated by being mixed with a phenolic material and a polyalkylene oxide and is then subjected to dewatering.
Patent NZ-506268-A (NZ)
Title: Buffer device constructed from punched and bent metal piece
Inventor: HAAB KARL
IPC: E05F5/00
Filed: 2000-03-14
Abstract: The buffer device (10) has a body (11) which can be fitted in a rail (4), a damping element (12) for cushioning, and a retaining spring (13) for retaining a running mechanism (6) which is guided in the rail (4) and is provided for carrying and guiding sliding wing elements (2). The at least approximately U-profile-shaped wing element of the buffer device (10), whose body is punched and bent from a metal element, has a first and a second wing (14; 18), these wings being connected to each other by a central piece (20) whose tongue-shaped extension forms the retaining spring (13) serving to retain the running mechanism (6). The end pieces (17, 19, 26) of the wings (14; 18) are configured in such a manner that they are suitable for retaining the damping element (12). The buffer device (10) can be manufactured cost-effectively from a single metal plate and can be completed by a damping element (12). Since the retaining spring (13) is a component part of the body (11) of the buffer device (10), the device is stated to be highly stable.
Patent NZ-508608-A (NZ)
Title: Modification of psyllium with enzymes such as cellulases, xylanases, hemicellulases, pentosanases, aribanases, beta-glucanases and mixtures thereof
Inventor: YU LIANGLI
IPC: A23L1/308
Filed: 1999-06-04
Abstract: Enzymatic treatment of raw psyllium involving adding raw psyllium to an aqueous dispersion containing a sufficient amount of an enzyme capable of modifying the carbohydrates of the raw psyllium.  Enzymes are selected from the group consisting of xylanases, cellulases, arabanases, hemicellulases, pentosanases, B-glucanases, and mixtures thereof.  Products containing the modified psyllium and methods for producing the same are also provided.
Patent NZ-508807-A (NZ)
Title: Calibration of frequency offsets for frequency-shift-keyed, FSK, pager transmissions
Inventor: SQUIRES PETER LECLERC
IPC: H03C3/08
Filed: 2000-12-12
Abstract: The frequency calibration process is carried out by a calibration circuit. The first portion of the calibration (77) is carried out by a Digital Signal Processor/Digital to Analog converter/Voltage Controller Thermal Compensation Oscillator (DSP/DACVCTCXO) arrangement. The second portion (78) is carried out by an Automatic Frequency Controller (AFC) and the third portion (79) is done using the DSP. The calibration can be initiated periodically or by an explicit request by a technician for example. The DSP/DAC/VCTCXO arrangement generates a test modulation signal (71) and sends it to the AFC. The AFC then generates an error signal (72) indicating the deviation of the modulated signal from a reference. The DSP uses this value to then make more precise estimates of adjustments to be made (73) before updating the calibration within a table (74).
Patent NZ-510820-A (NZ)
Title: Use of catechol derivatives as proteinase inhibitors
Inventor: SCHNEIDER JOHANNES
IPC: A61P17/02
Filed: 1999-09-23
Abstract: The invention relates to the use of catechol derivatives as proteinase inhibitors. The catechol derivatives are especially used for treating diseases from the group of rheumatoid arthritis, periodontitis, arteriosclerotic plaques, osteoporosis, arthrosis, matastatic spread, neoangiogenesis of tumors, ulceration of the cornea, and skin reactions resulting from exposure to UV radiation.
Patent NZ-512473-A (NZ)
Title: Power actuated tools
Inventor: FARRELL SIMON ALEXANDER
IPC: B25C1/14
Filed: 1999-12-08
Abstract: A power actuated tool for driving a fastener such as a pin into a substrate such as steel or concrete comprises a driving piston (6) which is driven forwardly within the barrel (4) of the tool upon firing and is automatically reset in response to cocking of the tool prior to the subsequent firing. Resetting of the piston takes place by thrusting the piston (6) rearwardly during cocking by means of a spring- loaded gripper device (14) energised during cocking.
Patent NZ-513130-A (NZ)
Title: Vaccine composition containing a monoglyceride adjuvant with inactivated Mycobacterium tuberculosis bacteria
Inventor: SCHRODER ULF
IPC: A61P39/06
Filed: 2000-02-09
Abstract: Tuberculosis (TB) vaccine composition comprising, an adjuvant, one or more substances selected from (a) monoglyceride preparations having at least 80% monoglyceride content that has the formula CH2(OR)-CH(OR)-CH2(OR) where R is H or acyl group containing 6 to 24 carbon atoms, provided that two of the R groups are H, and (b) a fatty acid with 6 to 24 carbon atoms, and an immunizing component, inactivated Mycobacterium tuberculosis bacteria.
Patent NZ-515611-A (NZ)
Title: Antibacterial compounds
Inventor: MILLER WILLIAM H
IPC: A61P31/04
Filed: 2000-06-01
Abstract: A compound according to formula (I) where: R1 is benzimidazolyl or pyridinyl, unsubstiuted or substituted by C1-4alkyl, OR", N(R")2, F, Cl, Br, I and CF3. R" is H or C1-6alkyl. R2 is H, C1-6alkyl, or Ar-C0-6alkyl, X is H, C1-4alkyl, OR', SR', C1-4alkylsulfonyl, C1-4alkylsulfoxyl, CN, N(R')2, CH2N(R')2, NO2, CF3, CO2R', CON(R')2, NR'C(O)R', F, Cl, Br, I or CF3S(O)r-; R' is H, C1-6alkyl or Ar-C0-6alkyl; and r is 0, 1 or 2. A process for preparing a compound of formula (I). Also, disclosed is the use of a compound of formula (I) for treating bacterial infections, and conditions where inhibition of Fab I is indicated.
Patent NZ-522445-A (NZ)
Title: Directly operated pneumatic valve having an air assist return
IPC: F16K11/07
Filed: 2002-11-06
Abstract: Disclosed is an air operated valve with spring biased and air assisted return operation.
Patent NZ-523778-A (NZ)
Title: Compositions for preventing urinary calculus
Inventor: YOSHIDA YASUNORI
IPC: A61K33/244
Filed: 2001-06-15
Abstract: A composition for preventing urinary calculi caused by metal ions liberated from a compound containing a lanthanoid metal or another heavy metal in image diagnosis or therapy using that compound, which comprises a multidentate ligand capable of forming a complex with lanthanoid metal ions or other heavy metal ions, or an alkaline earth metal complex of said ligand. The multidentate ligand can be a bifunctional ligand having a polyaminopolycarboxylic acid, polyaminopolyphosphonic acid or the like as its site for forming a complex with a metal and chemically bonded to a physiologically acceptable oligosaccharide or the like, or can also be a polyaminopolycarboxylic or polyaminopolyphosphonic acid per se.
Patent NZ-526002-A (NZ)
Title: Dual-polarization antenna array
Inventor: GOTTL MAXIMILIAN
IPC: H01Q21/24
Filed: 2002-09-27
Abstract: An improved antenna array comprising at least two groups of individual antennae (13) including a four dipoles and/or patch antennae having a square-shaped antenna structure. Said array is characterized in that, for each of the two mutually perpendicular polarizations, individual antennae (13, 13') mutually offset at least horizontally are used and/or for each of the two orthogonal polarizations at least two auxiliary antennae (215) mutually offset at least horizontally and/or at least two pairs of vertically oriented antennae are used, said pairs being arranged with respect to each other with a horizontal offset. Additionally, the different mutually horizontally offset and mutually parallel individual antennae are driven with a different phase position depending on the inclination angle.
Patent NZ-529421-A (NZ)
Title: Delivery of opioids through an inhalation route
Inventor: RABINOWITZ JOSHUA D
IPC: F24V30/00
Filed: 2002-05-21
Abstract: Disclosed is a composition for delivery of a therapeutic compound comprising a condensation aerosol formed by volatilising a therapeutic compound selected from the group consisting of naltrexone, buprenorphine, naloxone, butorphanol, hyrdromorphone, oxycodone, methadone, remifentanil or sufentanil under conditions effective to produce a heated vapour of the compound and condensing the heated vapour of the compound to form condensation aerosol particles; wherein said condensation aerosol particles are characterised by less than 4% compound degradation products; and the aerosol has a MMAD less than 5 microns.
Patent NZ-529518-A (NZ)
Title: Input method, system and device
Inventor: SONG ANDY ZHENG
IPC: G06F3/033
Filed: 2003-11-13
Abstract: A method of entering input into a computing system includes the steps of: (a) detecting input movements by means of panel including an array of sensors (3); (b) processing (8) the detected input movements by consulting a knowledge database (9) to identify a corresponding instruction signal for each detected input movement; and (c) transmitting the instruction signal to the computing system.
Patent NZ-530431-A (NZ)
Title: Azole derivatives useful as insecticide for controlling insects, acarines, molluscs and nematodes
Inventor: MATHEWS CHRISTOPHER JOHN
IPC: A01N43/80
Filed: 2002-07-26
Abstract: Azole derivatives of formula (I) are disclosed, wherein B is O or S; Het is a heterocycle selected from a number of specified heterocycles as defined in the specification and R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are each selected from specified groups as defined in the specification; provided that at least one of R6 and R10 is not hydrogen. Insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising these azoles and methods of using them to combat and control insect, acarine, mollusc and nematode pests are also disclosed.
Patent NZ-530454-A (NZ)
Title: Storage rack
Inventor: YANG QINGHAO
IPC: A47F3/14
Filed: 2003-12-24
Abstract: A storage rack includes a pivot shaft, a plurality of plastic trays pivoted to the pivot shaft, each tray having a plurality of upwardly protruded locating blocks, and flat accessory boxes of different sizes selectively and detachably carried in trays, each flat accessory box having a plurality of recessed bottom locating holes connectable to the locating blocks at the tray.
Patent NZ-533184-A (NZ)
Title: Lawnmower with stainless steel frame
Inventor: RIVOLTA PIERLUIGI
IPC: A01D34/81
Filed: 2003-02-19
Abstract: What is stated to be an "ecological lawnmower" with a stainless steel frame is disclosed, which is stated to eliminate the inconveniences of the traditional machines with iron or plastic frames due to having a number of advantages that up to now were unreachable in the field of lawnmowers.
Patent NZ-533334-A (NZ)
Title: Watering implement
Inventor: ROBINSON NORMAN GORDON
Filed: 2004-06-03
Abstract: A watering implement for watering plants. The implement has a hollow handle with a hose attachment means at one end for connection to a water source. A control valve is located on the handle to control water flow through the handle to a hollow head having at least two equally spaced hollow water injectors which extend therefrom. In use, the injectors are inserted below the surface of the soil to allow watering of roots of the plants.
Patent NZ-536603-A (NZ)
Title: A combination of an NMDA-antagonist and acetylcholine esterase inhibitors for the treatment of Alzheimer's disease
Inventor: THOMSEN LARS LYKKE
IPC: A61K31/55
Filed: 2003-05-22
Abstract: Disclosed is a use of a composition comprising: (a) an effective amount of one or more acetylcholinesterase (AChE) inhibitor (s) or a pharmaceutically acceptable salt thereof and (b) an effective amount of one or more NMDA-antagonist (s) or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of mild cognitive impairment or dementia in connection with moderate to severe Alzheimer's.
Patent NZ-538956-A (NZ)
Title: Benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivative used to inhibit dipeptidyl peptidase IV (DPPIV)
Inventor: FUKUSHIMA HIROSHI
IPC: A61P3/04
Filed: 2003-08-27
Abstract: Disclosed herein is a benzenesulfonate salt, namely (2S,4S)-2-cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate which shows an excellent dipeptidyl peptidase IV (DPPIV) inhibitory activity and has properties required as a medicine, for example, a high stability. This compound can be easily obtained in the form of highly stable crystals having a uniform shape and has a high solid stability. Pharmaceutical preparation containing this compound is suitable for preventing or treating diseases or conditions capable of being ameliorated by inhibition of dipeptidyl peptidase IV, as exemplified by diabetes mellitus (especially type II), immune diseases, arthritis, obesity, osteoporosis, conditions of impaired glucose tolerance, benign prostatic hyperplasia and skin diseases.
Patent NZ-542377-A (NZ)
Title: Maximum reaction rate converter system for exothermic reactions
Inventor: SINGH SHASHI PRAKASH
Filed: 2005-09-14
Abstract: Disclosed herein is a conversion process suitable for ammonia synthesis, comprising: introducing a gaseous reactant-rich stream at a feed temperature into a heat exchange passage of a heat exchanging reaction zone to pre-heat the reactant-rich stream to an inlet temperature; introducing the pre-heated reactant-rich stream at the inlet temperature into a countercurrent catalyst-containing reaction passage to exothermically convert the reactant gas to a product gas to form a product-enriched mixture of the reactant and product gases; indirectly transferring heat from the reaction passage to the heat exchange passage at a rate effective to maintain the mixture of gases below the equilibrium temperature; and recovering an effluent from an outlet from the reaction passage at a discharge temperature enriched in the product gas.
Patent NZ-544023-A (NZ)
Title: A flotation aid
Inventor: RANGIUAIA MOANA NUI A KIWA
Filed: 2005-12-08
Abstract: An inflatable flotation aid that allows a wearer 9 to be held in an upright position with their head out of the water is disclosed. The aid consists of a first tubular part 1 that extends directly downwards from the torso of the wearer 12, passes between their legs, and then extends directly upwards along their back. Second and third tubular parts 2, 3 branch off the first tubular part over the wearer's shoulders to the front of their torso where they are releasably attached by straps to the start of the first tubular part.
Patent NZ-547162-A (NZ)
Title: CD40 antibody formulation and methods
Inventor: BEDIAN VAHE
IPC: A61K39/395
Filed: 2004-12-09
Abstract: Provided is the use of a specified CD40 agonist antibody for the manufacture of a medicament for the treatment of cancer in a patient, wherein the medicament is formulated to provide a therapeutically effective amount of the antibody to the patient in combination with a therapeutically effective amount of a DNA replication inhibitor, which can be a platin derivative.
Patent NZ-549507-A (NZ)
Title: Carrying device
Inventor: GREEN LESLIE ARTHUR
Filed: 2006-08-28
Abstract: A hand protector (1) is disclosed. The hand protector (1) comprises a body having length, a bottom portion (2) able to rest against the inside of the hand, and at least a side wall portion (3a, 3b). This arrangement forms a channel for containing straps or handles laid lengthwise within the channel, and the size and dimensions of the hand protector (1) is commensurate to the size of a hand. There is tapering of the body in cross-section such that substantially along the body's length the side wall portion (3a, 3b) and bottom portion (2) of the body taper from the longitudinal centre line by an angle within the inclusive range of 5-30°.
Patent NZ-552510-A (NZ)
Title: N-(1-(1-benzyl-4-phenyl-1H-imidazol-2-yl)-2,2-dimethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (KSP) inhibitors for the treatment of cancer
Inventor: WANG WEIBO
IPC: A61K31/4174
Filed: 2005-06-20
Abstract: Disclosed herein are N-(1-(1-benzyl-4-phenyl-1H-imidazol-2-yl)-2,2-dimethylpropyl) benzamide derivatives represented by compounds of formula (I) wherein substitutents are as defined in the specification, as well as pharmaceutically acceptable salts, esters, compositions of these compounds together with pharmaceutically acceptable carriers and uses of these compounds. These substituted imidazole compounds are useful as kinesin spindle protein (KSP) inhibitors in the treatment of cancer.
Patent NZ-553061-A (NZ)
Title: Tamper-indicating printable sheet where microbeads are embedded in an ink receptive beadbond layer
Inventor: MARECKI PAUL E
IPC: B42D15/00
Filed: 2005-08-04
Abstract: A tamper-indicating printable sheet (10) is disclosed. The sheet (10) comprises a retro-reflective layer (18) comprising a plurality of microbeads (12) partially embedded in an inkjet receptive beadbond layer (14) and a reflector layer (20). This layer may be glued (16) to a suitable substrate (22). The reflector layer (20) is between each one of the microbeads (12) and the inkjet receptive beadbond layer (14). If the printed image (28) is removed the micro beads (12) will also be dislodged. This shows if the sheet (10) has been tampered with by no longer being reflective in that area or by displaying hidden printing (24).